- Home
- IART vs IMTX Comparison
IART vs IMTX Comparison
Compare IART & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IART
- IMTX
- Stock Information
- Founded
- IART 1989
- IMTX N/A
- Country
- IART United States
- IMTX Germany
- Employees
- IART N/A
- IMTX N/A
- Industry
- IART Medical/Dental Instruments
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- IART Health Care
- IMTX Health Care
- Exchange
- IART Nasdaq
- IMTX Nasdaq
- Market Cap
- IART 1.3B
- IMTX 1.1B
- IPO Year
- IART 1995
- IMTX N/A
- Fundamental
- Price
- IART $23.04
- IMTX $8.17
- Analyst Decision
- IART Hold
- IMTX Strong Buy
- Analyst Count
- IART 9
- IMTX 3
- Target Price
- IART $30.88
- IMTX $17.50
- AVG Volume (30 Days)
- IART 1.1M
- IMTX 500.2K
- Earning Date
- IART 11-04-2024
- IMTX 11-26-2024
- Dividend Yield
- IART N/A
- IMTX N/A
- EPS Growth
- IART N/A
- IMTX N/A
- EPS
- IART N/A
- IMTX N/A
- Revenue
- IART $1,564,920,000.00
- IMTX $75,935,926.00
- Revenue This Year
- IART $6.71
- IMTX $54.20
- Revenue Next Year
- IART $6.08
- IMTX N/A
- P/E Ratio
- IART N/A
- IMTX N/A
- Revenue Growth
- IART 1.45
- IMTX N/A
- 52 Week Low
- IART $16.81
- IMTX $7.94
- 52 Week High
- IART $45.42
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- IART 58.85
- IMTX 24.77
- Support Level
- IART $23.03
- IMTX $8.39
- Resistance Level
- IART $26.14
- IMTX $8.81
- Average True Range (ATR)
- IART 1.14
- IMTX 0.34
- MACD
- IART 0.05
- IMTX -0.04
- Stochastic Oscillator
- IART 59.20
- IMTX 14.89
About IART Integra LifeSciences Holdings Corporation
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.